1. Panthee S, Kito N., Hayashi T, Shimizu T, Ishikawa J., Osada H, and Takahashi S. Activation of LuxR family regulator by β-carboline chemical signals induced specialized metabolites in Gram-positive bacteria. Sci. Rep. (in review)
2. Paudel A#, Hamamoto H#, Panthee S#, Matsumoto Y, and Sekimizu, K. Large-scale screening and identification of novel pathogenic Staphylococcus aureus genes using a silkworm infection model. J. Infect. Dis: 2020 (in press)
3. Paudel A#, Panthee S#, Hamamoto H, and Sekimizu, K. GPI0363 inhibits the interaction of RNA polymerase with DNA in Staphylococcus aureus. RSC Adv: 2019, 9, 37889-37894
4. Panthee S, Paudel A, Blom J, Hamamoto H, and Sekimizu K. Complete genome sequence of Weissella hellenica 0916-4-2 and its comparative genomic analysis. Front Microbiol. 2019; 10, 1619
5. Brown P, RELISH Consortium, Zhou Y. Large expert-curated database for benchmarking document similarity detection in biomedical literature search. Database 2019 [Panthee S is the member of RELISH Consortium]
6. Itoh H, Tokumoto K, Kaji T, Paudel A, Panthee S, Hamamoto H, Sekimizu K, Inoue M. Development of a high-throughput strategy for discovery of superior analogues of antibiotic Lysocin E. Nat. Commun. 2019; 10, 2992
7. Nwibo DD#, Panthee S#, Hamamoto H, Sekimizu K. Molecular characterization of multi-drug resistant coagulase negative cocci in non-hospital environment. Drug Discov. Ther. 2019, 13 (3), 145-149
8. Panthee S, Takahashi S, Hayashi T, Shimizu T, and Osada H. β-carboline biomediators induce reveromycin production in Streptomyces sp. SN-593. Sci. Rep. 2019, 9, 5802.
9. Panthee S, Hamamoto H, Ishijima SA, Paudel A, Sekimizu K. Utilization of MinION long reads to determine the genome of an opportunistic pathogenic fungus, Candida albicans TIMM 1768. Genome Biol. Evol. 2018, 10 (8), 2017-2022.
10. Itoh H, Tokumoto K, Kaji T, Paudel A, Panthee S, Hamamoto H, Sekimizu K, Inoue M. Total Synthesis and Biological Mode of Action of WAP-8294A2: A Menaquinone-Targeting Antibiotic. J Org Chem. 2018, 83 (13), pp 6924–6935. (Outstanding Publication of the Year)
11. Paudel A, Panthee S, Urai M, Hamamoto H, Sekimizu K. Pharmacokinetic parameters explain the therapeutic activity of antimicrobial agents in silkworm infection model. Sci. Rep., 2018, 8, 1578.
12. Panthee B, Panthee S, Gyawali S, Kawakami N. Prevalence and correlates of substance use among health care students in Nepal: a cross sectional study. BMC Public Health, 2017, 17(1): 950.
13. Khalid A, Takagi H, Panthee S, Muroi M, Chappell J, Osada H, Takahashi S. Development of a Terpenoid-Production Platform in Streptomyces reveromyceticus SN-593. ACS Synth. Biol., 2017, 6 (12): 2339-2349.
14. Fujino H, Nagatomo M, Paudel A, Panthee S, Hamamoto H, Sekimizu K, Inoue M. Unified Total Synthesis of Polyoxins J, L, and Fluorinated Analogues on the Basis of Decarbonylative Radical Coupling Reactions. Angew. Chem. Int. Ed. Engl. 2017, 56 (39): 11865-11869.
15. Katsuyama A, Paudel A, Panthee S, Hamamoto H, Kawakami T, Hojo H, Yakushiji F, and Ichikawa S. Total synthesis and antibacterial investigation of plusbacin A3. Org. Lett., 2017, 19(14): 3771-3774.
16. Panthee S, Paudel A, Hamamoto H, Sekimizu K. Genomic analysis of vancomycin resistant Staphylococcus aureus VRS3b and its comparison with other VRSA isolates. Drug Discov. Ther., 2017, 11(2):78-8.
17. Panthee S, Paudel A, Hamamoto H, Sekimizu K. Draft genome sequence of vancomycin-resistant clinical isolate Staphylococcus aureus VRS3b. Genome Announc., 2017, 5 (22). pii: e00452-1.
18. Paudel A, Hamamoto H, Panthee S, Kaneko K, Matsunaga S, Kanai M, Suzuki Y, Sekimizu K. A novel spiro-heterocyclic compound identified by the silkworm infection model inhibits transcription in Staphylococcus aureus. Front. Microbiol., 2017, 8:712.
19. Panthee S, Paudel A, Hamamoto H, and Sekimizu K. Advantages of the silkworm as an animal model for developing novel antimicrobial agents. Front. Microbiol., 2017, 8: 373.
20. Panthee S, Hamamoto H, Suzuki Y, and Sekimizu K. In silico identification of lysocin biosynthetic gene cluster from Lysobacter sp. RH2180-5. J. Antibiot, 2017, 70, 204-207.
21. Panthee S, Hamamoto H, Paudel A, and Sekimizu K. Lysobacter species: a potential source of novel antibiotics. Arch. Microbiol., 2016, 198, 839-845.
22. Paudel A, Hamamoto H, Panthee S, and Sekimizu K. Menaquinone as a potential target of antibacterial agents. Drug Discov. Ther., 2016, 10, 123-128.
23. Paudel A, Panthee S, Shakya S, Amatya S, Shrestha TM, and Amatya MP. Analgesic, anti-inflammatory and other pharmacological activities of methanol extract of Rhododendron campanulatum from Nepal. Eur. J. Med. Plants, 2016, 13, 1-7.
24. Miyazawa T, Takahashi S, Kawata A, Panthee S, Hayashi T, Shimizu T, Nogawa T, and Osada H. Identification of middle chain fatty acyl-CoA ligase responsible for the biosynthesis of 2-alkylmalonyl-CoAs for polyketide extender unit. J. Biol. Chem., 2015, 290, 26994-7011.
25. Takahashi S, Toyoda A, Sekiyama Y, Takagi H, Nogawa T, Uramoto M, Suzuki R, Koshino H, Kumano T, Panthee S, Dairi T, Ishikawa J, Ikeda H, Sakaki Y, & Osada H. Reveromycin A biosynthesis uses RevG and RevJ for stereospecific spiroacetal formation. Nat. Chem. Biol., 2011, 7, 461–468.
26. Paudel A, Panthee S, Shakya S, Amatya S, Shrestha TM, and Amatya MP. Phytochemical and antibacterial properties of Rhododendron campanulatum from Nepal. Asian J Trad Med, 2011; 6, 6, 252-258.
27. Panthee S, Takahashi S, Takagi H, Nogawa T, Oowada E, Uramoto M, & Osada H. Furaquinocins I and J: Novel polyketide isoprenoid hybrid compounds from Streptomyces reveromyceticus SN-593. J. Antibiot 2011, 64, 509-513.
28. Panthee S, Panthee B, Shakya SR, Panthee N, Bhandari DR, and Bell JS. Nepalese pharmacy students' perceptions regarding mental disorders and pharmacy education. Am J Pharm Edu. 2010, 74, 89.
29. Panthee S*, Lohani SP. In-vitro adsorption studies of paracetamol to activated charcoal capsule, powder and suspension. The Open Toxicology Journal 2008, 2, 22-25.
30. Panthee S*. Prospect of new pharmacy college in Nepal. GPAN Bull 2007, 11, 69-71.
31. Panthee S*, Paudel A. Chronotherapy of hypertension: Yet more to find out. GPAN Bull 2006, 10, 19-22.
32. Panthee S*. Evaluation of prescribing errors in primary care. Int J Clin Pharmacol Ther, 2006, 44, 50-50.
33. Panthee S*. Essential drug list: Selection and challenges. Panacea, 2006, 2.
34. Panthee S*. General scenario of poisoning and its pattern in India. Hum Exp Toxicol, 2005, 24, 485-485.
35. Panthee S*. Surgery in rural Nepal. J Nep Med Assoc, 2005, 44, 67-67. PMID: 16554874.
36. Panthee S*. Good Manufacturing Training. GPAN Bull, 2005, 9, 22-25.
37. Panthee S*. International Pharmaceutical Students' Federation to launch Pharmacy Profession Awareness Campaign. GPAN Bull, 2004, 8, 14-14.